SAVA Stock – Knox Daily

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cassava Sciences

Analysts Viewpoint

Cassava Sciences Inc’s filing revealed that its Chief Medical Officer Kupiec James William unloaded Company’s shares for reported $15480.0 on

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

Cassava Sciences Inc’s recent filing unveils that its Chief Medical Officer Kupiec James William unloaded Company’s shares for reported $15480.0

Analysts Viewpoint

Cassava Sciences Inc’s recently made public that its Chief Medical Officer Kupiec James William unloaded Company’s shares for reported $15480.0

Insiders Updates

As this happened, H.C. Wainwright downgraded its Cassava Sciences Inc [SAVA] rating to a Neutral from a a Buy in

Stock Earnings

Taking this into account, H.C. Wainwright upgraded its Cassava Sciences Inc [SAVA] rating to a Buy from a a Neutral

Featured

Cassava Sciences, Inc. (SAVA) has seen a push of 7.26% in the aftermarket because the company announced that petition filed

Featured

U.S. stocks posted broad declines yesterday as investors grew cautious in the wake of Fed Chairman Jay Powell’s Wednesday comments

Featured

The biotech company Cassava Sciences updates that its Alzheimer’s drug, sumifilam, recorded positive results in treating Alzheimer’s patients in a

Tag: SAVA Stock